[PHARMA] YoY Cumulative Quarter Result on 31-Dec-2017 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
27-Feb-2018
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Dec-2017 [#4]
Profit Trend
QoQ- 68.08%
YoY- 18.04%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 2,725,071 2,820,530 2,384,956 2,323,960 2,189,022 2,189,312 2,122,933 4.24%
PBT 35,793 -191,865 70,220 73,064 72,017 112,722 125,580 -18.86%
Tax -9,524 42,418 -26,990 -17,977 -26,158 -28,138 -31,355 -17.99%
NP 26,269 -149,447 43,230 55,087 45,859 84,584 94,225 -19.15%
-
NP to SH 27,489 -149,219 42,468 53,823 45,599 84,044 93,844 -18.49%
-
Tax Rate 26.61% - 38.44% 24.60% 36.32% 24.96% 24.97% -
Total Cost 2,698,802 2,969,977 2,341,726 2,268,873 2,143,163 2,104,728 2,028,708 4.86%
-
Net Worth 337,298 336,573 509,862 526,888 531,169 529,482 525,526 -7.11%
Dividend
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Div 28,761 22,177 41,621 49,314 41,457 77,674 72,486 -14.26%
Div Payout % 104.63% 0.00% 98.01% 91.62% 90.92% 92.42% 77.24% -
Equity
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Net Worth 337,298 336,573 509,862 526,888 531,169 529,482 525,526 -7.11%
NOSH 261,705 261,229 260,505 259,821 259,377 258,915 258,880 0.18%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 0.96% -5.30% 1.81% 2.37% 2.09% 3.86% 4.44% -
ROE 8.15% -44.33% 8.33% 10.22% 8.58% 15.87% 17.86% -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 1,042.20 1,081.04 916.82 895.38 844.83 845.57 820.05 4.07%
EPS 10.51 -57.19 16.33 20.74 17.60 32.46 36.25 -18.63%
DPS 11.00 8.50 16.00 19.00 16.00 30.00 28.00 -14.40%
NAPS 1.29 1.29 1.96 2.03 2.05 2.045 2.03 -7.27%
Adjusted Per Share Value based on latest NOSH - 259,821
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
RPS 189.08 195.70 165.48 161.25 151.89 151.91 147.30 4.24%
EPS 1.91 -10.35 2.95 3.73 3.16 5.83 6.51 -18.46%
DPS 2.00 1.54 2.89 3.42 2.88 5.39 5.03 -14.23%
NAPS 0.234 0.2335 0.3538 0.3656 0.3686 0.3674 0.3646 -7.11%
Price Multiplier on Financial Quarter End Date
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 31/12/15 31/12/14 -
Price 5.00 2.06 2.78 4.60 5.30 6.36 4.58 -
P/RPS 0.48 0.19 0.30 0.51 0.63 0.75 0.56 -2.53%
P/EPS 47.56 -3.60 17.03 22.18 30.12 19.59 12.63 24.70%
EY 2.10 -27.76 5.87 4.51 3.32 5.10 7.91 -19.81%
DY 2.20 4.13 5.76 4.13 3.02 4.72 6.11 -15.64%
P/NAPS 3.88 1.60 1.42 2.27 2.59 3.11 2.26 9.41%
Price Multiplier on Announcement Date
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Date 17/03/21 20/02/20 21/02/19 27/02/18 21/02/17 15/02/16 23/02/15 -
Price 3.49 2.04 2.76 4.04 5.12 6.19 5.28 -
P/RPS 0.33 0.19 0.30 0.45 0.61 0.73 0.64 -10.44%
P/EPS 33.20 -3.57 16.91 19.48 29.09 19.07 14.57 14.69%
EY 3.01 -28.04 5.92 5.13 3.44 5.24 6.87 -12.83%
DY 3.15 4.17 5.80 4.70 3.13 4.85 5.30 -8.29%
P/NAPS 2.71 1.58 1.41 1.99 2.50 3.03 2.60 0.69%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment